Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117137) titled 'The value and significance of dd-cfDNA combined with immunological function tests in transplanted liver insufficiency' on Jan. 20.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Tongji Hospital, Huazhong University of Science and Technology
Condition:
Rejection after liver transplantation
Intervention:
Acute Rejection:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2022-01-01
Target Sample Size: Acute Rejection:18;Acute Dysfunction No Rejection:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?pro...